OD-00910

N/A

Report date: 2025/02/25 15:36:20

Base Information

Drug NameOD-00910
Drug Alias NameOD-00910
ClassificationBiologics > Protein drugs
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B agonists
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsDiabetes Mellitus, Type 1VitiligoLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOdyssey Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOdyssey Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1VitiligoLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A